The progression of AD is characterized by an alteration in lysosome dynamics (LAMP1), an upregulation of amyloid associated proteins (APP, PrP, and ENPP2), and an induction of neurite regeneration (GAP43) (144). This evidence concerns the gene GAP43 and Alzheimer disease.